Her lab did this through a large
genetic suppressor screen using the fruit fly, Drosophila melanogaster.
Not exact matches
Using a genome - wide
genetic screen, Dr. Gelman and colleagues identified a previously unknown metastasis
suppressor — the FOXO4 protein, which belongs to a family of genes that are produced by all human cells.
One known miR - 182 target is CHEK2, a known tumor
suppressor and suspected
genetic risk factor for high - tension glaucoma.
If tumors have this PPM1D mutation, they do not have another more common
genetic mutation to the TP53 gene, a tumor
suppressor that, when defective, is linked to half of all cancers.
Rather than target a tumor -
suppressor gene directly, Ideker and team took the approach of identifying
genetic interactions between a tumor
suppressor gene and another gene, such that simultaneous disruption of both genes selectively kills cancer cells.
Through
genetic engineering techniques, it is now possible to introduce
suppressor (Su +) tRNA molecules into mammalian cells.
This common
genetic heritage is a potential achilles heel of the metastases, however, many of these shared mutations are in tumor
suppressor genes and our approach to therapeutically targeting these needs to be prioritised.
As a powerful tumor
suppressor, p53 turns on genes that either halt cell division to allow time for repair of damaged DNA or, when all rescue attempts prove futile, to prevent cells with
genetic defects from dividing, as this would fuel the development of cancer.
In back - to - back papers published online July 28 in Science, researchers from the Broad Institute, Dana - Farber Cancer Institute, Johns Hopkins Kimmel Cancer Center, the University of Pittsburgh, and the University of Texas MD Anderson Cancer Center have confirmed
genetic abnormalities previously suspected in head and neck cancer, including defects in the tumor
suppressor gene known as p53.
Moreover, large - scale screens in the C. elegans DMD model allowed identifying
genetic and pharmacologic
suppressors of dystrophin - dependent muscle degeneration; some of them positively impact mitochondrial functions or structure under stress conditions, or are involved in signaling pathways linked to mitochondria, and others are associated to proteostasis pathways such as autophagy, proteasome and Unfolded Protein Response (UPR).
The suppression of LCMV - specific CTL responses by carrier spleen cells is not mediated by a
suppressor cell, but is due to the presence of
genetic variants of LCMV in spleens of carrier mice.
This prompted us to characterize in more detail shared mechanisms and pathways and to target them with
genetic and pharmacologic means so as to identify some broadly efficient
suppressors of muscle degeneration.
Dr. Eng and team create scoring system to facilitate identifying individuals to be referred to PTEN gene testing Researchers have discovered a method for more precise identification of individuals who should undergo testing for
genetic mutations of the tumor
suppressor gene PTEN, which associates with a variety of conditions including several types of cancers.
Here, we have used a
genetic approach to address the function of RASSF1A as a tumor
suppressor in vivo by targeted deletion of Rassf1A in the mouse.
Additionally, alterations of subcellular localization through aberrant splicing or
genetic mutations also provide ways to inactivate tumor
suppressor genes (50).
Genetic mutations that alter tumor
suppressors such as the p53 gene are known to help tumors grow, and epigenetic modifications, too, can deactivate genes like this one.
Genetic testing to look at detoxification pathways, tumor
suppressor genes, defects to metabolic pathways that may «feed» cancer cells, and more.